Which of the following regimens is acceptable for prostatitis in a mature male with prostatic secretions showing inflammation?

Prepare effectively for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 1 Exam with comprehensive resources, flashcards, and detailed explanations. Ace your test with ease!

Multiple Choice

Which of the following regimens is acceptable for prostatitis in a mature male with prostatic secretions showing inflammation?

Explanation:
Antibiotics for prostatitis must reach the prostate in effective concentrations and cover the usual pathogens, mainly Enterobacteriaceae such as E. coli. Trimethoprim-sulfamethoxazole given twice daily penetrates prostatic tissue well and is active against these organisms, making a three-week course a reasonable option for prostatitis treatment in many cases. The other regimens are less suitable for this condition. A fluoroquinolone for only ten days doesn’t provide an adequate duration for prostatitis, where several weeks are typically needed. A combination of ampicillin and gentamicin is less ideal because aminoglycosides have poor penetration into prostatic tissue, reducing effectiveness against prostatitis pathogens. Metronidazole targets anaerobes and has limited activity against the common Gram-negative prostatitis agents, so it wouldn’t be an appropriate first-line choice.

Antibiotics for prostatitis must reach the prostate in effective concentrations and cover the usual pathogens, mainly Enterobacteriaceae such as E. coli. Trimethoprim-sulfamethoxazole given twice daily penetrates prostatic tissue well and is active against these organisms, making a three-week course a reasonable option for prostatitis treatment in many cases.

The other regimens are less suitable for this condition. A fluoroquinolone for only ten days doesn’t provide an adequate duration for prostatitis, where several weeks are typically needed. A combination of ampicillin and gentamicin is less ideal because aminoglycosides have poor penetration into prostatic tissue, reducing effectiveness against prostatitis pathogens. Metronidazole targets anaerobes and has limited activity against the common Gram-negative prostatitis agents, so it wouldn’t be an appropriate first-line choice.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy